FPT Software and Vilja Join Forces to Advance Digital Banking
10.9.2024 08:21:00 CEST | Business Wire | Press release
Global IT company FPT Software recently announced a strategic partnership with Nordic-leading core banking service provider, Vilja. As a global technology partner to Vilja, FPT Software aims to fortify its financial services portfolio to deliver more innovative digital banking solutions to customers worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240909234829/en/
The signing ceremony took place at the Vietnam-Sweden Economic Forum in Stockholm, Sweden. (Photo: Business Wire)
Leveraging FPT Software's extensive technical expertise and global reach, this partnership will introduce Vilja’s cloud-native, application programming interface (API)-first banking platform to global enterprises, with an initial focus on Asia's rapidly growing digital economy. This collaboration also includes the establishment of an R&D center in Asia, dedicated to pioneering diverse innovations that cater to the evolving demands of digital banking, particularly in areas like deposits and loans.
“With over two decades of experience in delivering digital solutions to global leaders in BFSI, FPT Software is confident that our partnership with Vilja will further empower financial institutions with enhanced security, scalability, and user experience. By combining our industry expertise and global presence with Vilja's innovative solutions, we aim to set new standards and help financial institutions thrive in today’s fast-paced digital landscape,” said Dzung Tran, CEO of FPT Software Europe.
“Vilja is now expanding globally from a strong position as the Nordic market leader and with global recognition for our cloud-native core banking solutions. Our partnership with FPT Software further strengthens this position and is a testimony to our leading innovation and capacity that sends a clear signal to the market. With FPT’s experience, expertise, and trusted reputation we have a global reach starting from Southeast Asia with our focused expansion in the ASEAN countries,” said Fredrik Ulvenholm, CEO of Vilja Solutions.
Boasting over a decade of operation in the European market, FPT Software is now a trusted partner in digital transformation, providing end-to-end services and innovative solutions to more than 150 European leading companies across industries, such as E.ON, Schaeffler, Viessmann, Covestro, Volvo, and Siemens. The IT firm has expanded its presence to nine countries, most recently with the opening of its Swedish office.
The signing ceremony took place at the Vietnam-Sweden Economic Forum in Stockholm, Sweden, with the participation of the Vietnamese Ambassador to Sweden H.E. Tran Van Tuan, Mdm. Camilla Mellander, Director-General for Trade Policy at the Swedish Ministry for Foreign Affairs, FPT Corporation Chairman Dr. Truong Gia Binh, Vilja Chairman Greger Fellin, together with leaders from 50 companies and organizations.
About FPT Software
FPT Software, a subsidiary of FPT Corporation, is a global technology and IT services provider headquartered in Vietnam, with $1 billion in revenue (2023) and over 30,000 employees in 30 countries.
The company champions complex business opportunities and challenges with its world-class services in Advanced Analytics, AI, Digital Platforms, Cloud, Hyperautomation, IoT, Low-code, and so on. It has partnered with over 1,100 clients worldwide, nearly 100 of which are Fortune Global 500 companies in Aviation, Automotive, Banking, Financial Services and Insurance, Healthcare, Logistics, Manufacturing, Utilities, and more. For more information, please visit https://fptsoftware.com/
About Vilja
Vilja technology was created in one of Europe’s first digital banks and is today the leading Nordic cloud-native core banking platform vendor, empowering banks and financial institutions with cutting-edge innovation and digital banking solutions. Our pre-packaged deposit and lending solutions feature a modular design, allowing you to select an end-to-end solution or specific products tailored to your needs. The platform is highly automated and configurable, ensuring rapid time-to-market and enhanced operational efficiency. Our ASEAN headquarters are located in Kuala Lumpur Malaysia. For more information, visit viljasolutions.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240909234829/en/
Contacts
Mai Duong (Ms.)
Mai Duong (Ms.)
FPT Software
PR Manager
MCP.PR@fpt.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom